Stock ELYM ELIEM THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Market Closed - Nasdaq
Other stock markets
 21:00:00 01/07/2024 BST 		5-day change 1st Jan Change
7.05 USD -0.84% Intraday chart for Eliem Therapeutics, Inc. -6.87% +161.11%
06-28 Eliem Therapeutics Joining Russell 2000, 3000 Indexes MT
06-27 Eliem Therapeutics Acquires Tenet Medicines, Closes $120 Million Stock Placement, Names New CEO MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Eliem Therapeutics Joining Russell 2000, 3000 Indexes
MT
Eliem Therapeutics Acquires Tenet Medicines, Closes $120 Million Stock Placement, Names New CEO
MT
Eliem Therapeutics, Inc. completed the acquisition of Tenet Medicines, Inc. from RA Capital Management, L.P. and others.
CI
Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Sector Update: Health Care Stocks Softer Late Afternoon
MT
Top Midday Gainers
MT
Sector Update: Health Care Stocks Decline Thursday Afternoon
MT
Eliem Therapeutics to Acquire Tenet Medicines; Launching Private Placement -- Eliem Shares Surge
MT
Top Premarket Gainers
MT
Eliem Therapeutics, Inc. entered into a definitive acquisition agreement to acquire Tenet Medicines, Inc.
CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Eliem Therapeutics Plans to Explore Strategic Alternatives
CI
Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
North American Morning Briefing : Stock Futures -3-
DJ
Eliem Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Eliem Therapeutics, Inc. Provides Update on Pipeline Progress
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ELYM Stock
  4. News Eliem Therapeutics, Inc.
  5. Highlights